Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3521
0.00 (0.00%)
At close: May 14, 2026

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.63-19.86-29.92-39.26-28.26-8.52
Stock-Based Compensation
1.892.231.633.410.180.15
Other Operating Activities
-0.03-0.09-0.720.240.19-1.59
Change in Accounts Payable
-2.82-3.412.290.333.01-0.5
Change in Other Net Operating Assets
-2.62-3.46-6.836.965.92-0.2
Operating Cash Flow
-20.2-24.59-33.54-28.32-18.96-10.67
Short-Term Debt Issued
-0.410.980.67--
Total Debt Issued
0.410.410.980.67--
Short-Term Debt Repaid
--0.46-0.52-0.67--
Total Debt Repaid
-0.4-0.46-0.52-0.67--
Net Debt Issued (Repaid)
0.01-0.050.46---
Issuance of Common Stock
37.125.6123.1933.177.7931.6
Financing Cash Flow
37.125.5623.6533.177.7931.6
Net Cash Flow
16.90.96-9.894.85-11.1720.93
Cash Interest Paid
0.010.010.020.03--
Cash Income Tax Paid
0000.02-0
Levered Free Cash Flow
-14.16-17.14-21.54-14.01-8.54-6.87
Unlevered Free Cash Flow
-14.15-17.13-21.52-13.99-8.54-6.87
Change in Working Capital
-5.44-6.87-4.547.288.93-0.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.